文献速递神经儿科影像MR

儿童增强磁共振检查后脑组织钆滞留:病理学证实

Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
PubMed 文献 · Pediatr Radiol · 2020-01-27

该研究对10例1岁至13岁、至少接受过一次增强MR检查的儿童脑尸检标本行电感耦合等离子体质谱分析,所有儿童脑组织均检出钆,苍白球最高;仅使用大环类对比剂者钆滞留水平较低,分布与成人相似;作者认为应谨慎并避免不必要的儿童钆对比剂使用。

要点

  • 儿童增强MR后脑组织可病理证实钆滞留,苍白球浓度最高。
  • 仅用大环类对比剂的儿童钆滞留水平低于使用线性类者。
  • 儿童钆沉积的临床意义尚不明确,作者建议避免不必要使用。

核心结论

  • 病理学证实儿童脑组织存在钆滞留,分布和沉积水平与成人所见相当;临床意义尚不明确,作者认为目前应谨慎并避免不必要的儿童钆对比剂使用。

研究设计与样本

  • 研究分析10例1岁至13岁、至少接受过一次增强MR检查的儿童脑尸检标本,用ICP-MS检测脑组织钆含量,取材包括白质、基底节(壳核、苍白球)、丘脑、齿状核及肿瘤组织(视情况)。
  • 记录每例儿童的对比剂类型和剂量、增强MR次数和时间以及肾功能(eGFR)。

关键影像表现/征象

  • 所有儿童脑组织均检出钆,一般以苍白球最高。
  • 仅接受大环类对比剂的儿童钆滞留水平较低。
  • 钆滞留分布和沉积水平与成人所见相当。

临床应用与阅片要点

  • 儿童增强MR后脑组织钆滞留已有病理学证据,阅片和报告中需考虑既往钆对比剂暴露史。
  • 仅用大环类对比剂的儿童钆滞留水平较低,但本研究也证实使用大环类(非离子和离子化合物)后仍存在滞留。
  • 作者认为目前应谨慎并避免不必要的儿童钆对比剂使用。

局限性

  • 儿童患者病理学证实有限。
  • 本研究样本量小(10例)。
  • 钆滞留的临床意义尚不明确。
  • 暴露年龄对钆滞留的影响尚不明确。
  • GBCA洗脱率差异仍在研究中,可能影响钆滞留与GBCA给药时间的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Retained gadolinium from gadolinium-based contrast agents (GBCAs) used in MR exams has been inferred based on signal changes on serial brain MRI and subsequently demonstrated pathologically in adults. Retention has been similarly inferred in children but pathological demonstration in pediatric patients is limited. The long-term effects of retained gadolinium are unknown but are potentially of greater concern in children given their increased vulnerability from continuing development and their expected longer period of exposure. Several factors can influence gadolinium retention. In adults as well as in children, greater accumulation has been demonstrated based on MR signal changes with linear compared with macrocyclic gadolinium chelates, attributed to lower chelate affinity with linear agents. Effects of age at exposure on retention are unknown, while differences in GBCA washout rates are still under investigation and might affect gadolinium retention relative to time of GBCA administration.

OBJECTIVE: The purpose of this study was to confirm whether gadolinium brain deposits are present in pediatric patients who received GBCAs and to quantify the amounts present.

MATERIALS AND METHODS: Brain autopsy specimens from 10 pediatric patients between 1 year and 13 years of age who underwent at least one contrast-enhanced MR exam were analyzed for elemental gadolinium using inductively coupled plasma mass spectrometry. Brain samples included white matter, basal ganglia (putamen, globus pallidus), thalamus, dentate nucleus and tumor tissue as available. Type and dose of contrast agent, number and timing of contrast-enhanced MR exams and renal function (estimated glomerular filtration rate [eGFR]) were documented for each child.

RESULTS: Patient exposures ranged from 1 dose to 20 doses of GBCAs including both macrocyclic and linear ionic agents. Gadolinium was found to be present in brain tissue in all children and was generally highest in the globus pallidus. Those who received only macrocyclic agents showed lower levels of gadolinium retention.

CONCLUSION: This study demonstrates pathological confirmation of gadolinium retention in brain tissue of a series of pediatric patients exposed to GBCAs including not only linear ionic agents but also macrocyclic agents with both nonionic and ionic compounds. The distribution and deposition levels in this small pediatric population are comparable with the findings in adults. While the clinical significance of these deposits remains unknown, at this point it would be prudent to exert caution and avoid unnecessary use of GBCAs in pediatric patients.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Stanescu AL, Shaw DW, Murata N, et al. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation. Pediatr Radiol. 2020. PMID: 31989188. doi:10.1007/s00247-019-04535-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。